Botched butt jobs

[HokieDNA01]

shit those girls could have some of my big white booty. Well actually that has since shrunk but hopefully won't go completely away. Its my defining feature lol.

[tommymac]

Originally Posted by HokieDNA01

shit those girls could have some of my big white booty. Well actually that has since shrunk but hopefully won't go completely away. Its my defining feature lol.

That means I iwll have ot bite it attthe rally to be sure

[Homeslice]

Originally Posted by Papa_Complex

Just results in flat HARD butts.

I'm gonna disagree, resistance training (or hardcore sports like sprinting or speed-skating) can increase a butt's size.

Now, if all she does is run or use treadmills, she'll remain flat or get even flatter.

[Avatard]

Know what tightens up and shapes a woman's ass? Fucking.

Reverse cowgirl uses all the right muscle groups.

Got that ladies? Get to it.

[tommymac]

Actualy got an e-mail from the NYC DOH on these cases and to be on the look out for them. Not sure i would be so nice or compassionate if one rolled into my ER.

Sorry mam but that caulk will make your ass fall off

heres the e-mail:

Dear HAN Subscriber:

We have just released a DOHMH Alert concerning infections following cosmetic injections. It is available on the HAN home page, is appended to this email, and is also attached as a pdf file. To read the attachment, you will need the Adobe reader. If you do not have that software, it can be downloaded at no cost at http://www.adobe.com/products/acrobat/readstep2.html.


To log into the HAN, for this alert and many related documents, go to www.nyc.gov/health/nycmed. If you have any questions or problems with accessing or using the HAN website, call 1-888-NYCMED9 or write to nycmed@health.nyc.gov.

2010 Alert # 3: Cluster of infections following cosmetic injections

• New Jersey (NJ) health officials are investigating a cluster of serious infections among NJ residents who received cosmetic injections for buttock augmentation, possibly administered by unlicensed providers
• Epidemiologic investigations are in progress, but one ill NJ patient reported receiving injections in New York City (NYC)
• Nocardia spp. have been isolated from the cultures of three patients
• The Department of Health and Mental Health (DOHMH) is requesting providers to obtain a history on cosmetic injections/procedures for patients presenting with cellulitis, soft tissue infection or abscess of the buttocks
• Consider atypical organisms in the differential when managing patients with infections following cosmetic procedures
• Report cases promptly to the DOHMH’s Bureau of Communicable Disease
• Submit positive isolates from infections secondary to cosmetic injections to the Public Health Laboratory

Please Distribute to All Clinical Staff in Primary Care, Internal Medicine, Emergency Medicine, Infectious Diseases, Dermatology, General and Plastic Surgery, Laboratory Medicine (including Mycobacteriology Laboratory staff) and Infection Control Staff

March 10, 2010

Dear Colleagues,

The New York City Department of Health and Mental Hygiene (DOHMH) has been notified of six cases of cellulitis/subcutaneous abscesses in New Jersey residents who received injections of unknown substances into the buttocks for cosmetic purposes. There have been no cases reported among New York City residents, but one patient from New Jersey reported receiving her injections in a private residence in New York City.

All of the cases occurred in young women who received the cosmetic injections between November 2009 and February 2010. The six patients presented with buttock cellulitis and abscesses requiring incision and drainage approximately two to four weeks following their injections; all were hospitalized. No deaths have been reported, but some patients have required long-term outpatient antibiotic therapy.

The New Jersey Department of Health and Senior Services and local health officials in New Jersey are actively investigating the ca ses, and preliminary information suggests the injections may have been performed by unlicensed individuals. Nocardia spp. has been identified in cultures obtained from abscesses from three of the six New Jersey cases; cultures are pending still for the other cases.

Previous incidents of infections associated with cosmetic procedures performed by unlicensed providers have occurred in New York City, though with different organisms. The NYC DOHMH investigated a cluster of cutaneous Mycobacterium abscessus infections in 2002 and a case of cutaneous Mycobacterium fortuitum infection in 2005.

Nocardia include a number of species normally found in soil, organic matter, and water. Although health care providers evaluating individuals with infections following cosmetic injections should consider typical organisms such as Streptococcus and Staphylococcus, atypical organisms such as Nocardia spp. and Mycobacterium spp. also should be included in the differential. The se atypical organisms can present with more indolent skin lesions and may not respond to usual empiric antimicrobial regimens. Strong consideration should be given to consultation with an infectious diseases specialist when managing patients infected with Nocardia spp. and other atypical organisms.

Providers should obtain a history on injections/procedures for cosmetic or other purposes from any patient presenting with buttock cellulitis, soft tissue infection or cutaneous abscess. In addition, providers should consider incision and drainage for any buttock abscess, and send wound specimens to a laboratory for Gram stain and culture.

To identify additional cases of infections secondary to cosmetic injections, we request that health care providers, including laboratorians:

1. Review clinical and laboratory records and report any cases of buttock abscesses from which Nocardia spp. were isolated since November 1, 2009;
2. Report any new cases of bu ttock cellulitis, soft tissue infection, or cutaneous abscess following cosmetic injections;
3. In the absence of a history of cosmetic injections, report any new case of buttock abscess from which Nocardia spp. or atypical Mycobacterium are isolated.
4. Coordinate with your Microbiology laboratory to forward any Nocardia and Mycobacterium spp. isolated from buttock abscesses to the New York City Public Health Laboratory (see detailed information below).

Please report all cases to the Bureau of Communicable Disease:
During business hours: 212-788-9830
After hours, call the Poison Control Center: 212-764-7667 or 1-800-222-1222

For laboratorians:
The following media will support the growth of Nocardia spp.: blood agar, chocolate agar, brain heart infusion agar, Sabouraud dextrose agar and Lowenstein-Jensen media (LJ). Buffered charcoal yeast extract medium (BCYE) is also very useful for the recovery of Nocardia spp. When sending isola tes to the Public Health Laboratory (PHL) for identification, Nocardia spp should be sent on either blood or chocolate agar using the NYC PHL General Bacteriology requisition form, available at: http://www.nyc.gov/html/doh/download...o-fillable.pdf

For atypical mycobacteria, the use of liquid and at least one solid media for the isolation of Mycobacteria is recommended (e.g., LJ &/or 7H10 media plus 7H9 broth). Atypical mycobacteria isolates should be sent either on LJ or 7H10 media. Isolates will be accepted in 7H9 broths (or equivalent) if growth on solid media is not readily available. These isolates should be submitted together with the NYC PHL Mycobacteriology requisition form: http://www.nyc.gov/html/doh/download...forms-tb_f.pdf

As always, we appreciate our ongoing partnership with the New York City medical and laboratory community in helping us identify and investigate unusual disease manifestations and clusters.

Sincerely,

Ellen Lee, MD
Medical Director, General Surveillance Unit
Bureau of Communicable Disease

Don Weiss, MD, MPH
Director of Surveillance
Bureau of Communicable Disease